The SPTBN2 gene plays a crucial role in the proper functioning of the cerebellum, a part of the brain that coordinates movement and balance. Mutations in the SPTBN2 gene are associated with Spinocerebellar Ataxia Type 5 (SCA5), a rare, inherited neurological disorder characterized by progressive problems with movement and coordination. This condition is autosomal dominant, meaning that a mutation in just one of the two copies of the gene is sufficient to cause the disorder.
To diagnose SCA5, genetic testing is performed to identify mutations in the SPTBN2 gene. DNA Labs UAE offers a comprehensive genetic test specifically designed to detect these mutations. The test is crucial for individuals with a family history of SCA5 or those exhibiting symptoms related to the condition, such as difficulty with coordination and balance, to confirm the diagnosis and understand their genetic status.
The cost of the SPTBN2 gene test at DNA Labs UAE is 4400 AED. This investment provides individuals and their healthcare providers with essential information that can guide management and treatment options, as well as inform family planning decisions. Early diagnosis through genetic testing can significantly impact the quality of life for those with SCA5 and their families by enabling timely interventions and support.
The "CACNA1A Gene Spinocerebellar Ataxia Type 6 Autosomal Dominant Genetic Test" is a specialized diagnostic examination conducted to identify mutations in the CACNA1A gene, which are implicated in Spinocerebellar Ataxia Type 6 (SCA6). SCA6 is a genetic disorder characterized by progressive degeneration of the cerebellum, leading to coordination and balance difficulties, among other symptoms. This condition follows an autosomal dominant inheritance pattern, meaning that an affected individual has a 50% chance of passing the mutation to their offspring.
The test is specifically designed to detect the presence of genetic alterations within the CACNA1A gene, which encodes a subunit of a calcium channel that plays a critical role in the functioning of nerve cells, particularly in the cerebellum. Mutations in this gene disrupt the normal flow of calcium ions, leading to the symptoms associated with SCA6.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis for individuals presenting symptoms of SCA6 or those with a family history of the disorder. It is a crucial step in confirming the diagnosis, understanding the risk of transmission to future generations, and guiding management and treatment options.
The cost of the "CACNA1A Gene Spinocerebellar Ataxia Type 6 Autosomal Dominant Genetic Test" at DNA Labs UAE is set at 4400 AED. This investment covers the technical processes of detecting the specific genetic mutation, professional analysis, and the provision of a detailed report on the findings. It's an essential tool for individuals and families seeking clarity on their genetic status concerning SCA6, facilitating informed decisions regarding health and family planning.
The ATXN7 gene spinocerebellar ataxia type 7 (SCA7) autosomal dominant genetic test is a specialized diagnostic procedure aimed at identifying mutations in the ATXN7 gene, which are known to cause spinocerebellar ataxia type 7. This condition is characterized by progressive deterioration of motor skills, coordination, and vision, resulting from the degeneration of specific areas in the cerebellum and retina. As an autosomal dominant disorder, only one copy of the mutated gene inherited from an affected parent is sufficient to cause the condition.
This genetic test involves analyzing the patient's DNA, extracted from a blood sample, to look for specific mutations in the ATXN7 gene that are indicative of SCA7. The process is vital for individuals with a family history of the condition or those exhibiting symptoms, as it can confirm the diagnosis, inform about the progression of the disease, and aid in family planning decisions.
The test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the test is 4400 AED, reflecting the specialized nature of the procedure and the sophisticated technology employed. Upon completion, the results provide crucial information for the management and treatment of affected individuals, offering them and their families a clearer understanding of the condition and how to navigate its challenges.
The TPP1 gene, associated with Spinocerebellar Ataxia Type 7 (SCA7), is a critical marker for this autosomal recessive genetic disorder. SCA7 is a progressive, neurodegenerative condition characterized by a loss of coordination, affecting movements and balance due to cerebellar ataxia. The condition can also lead to vision loss and other systemic symptoms. The genetic test for TPP1 gene mutations offers a definitive diagnosis, enabling early intervention and management strategies for affected individuals and their families.
At DNA Labs UAE, a specialized genetic test targeting the TPP1 gene linked to Spinocerebellar Ataxia Type 7 is available. This test is crucial for individuals with a family history of SCA7 or those exhibiting symptoms suggestive of the condition. The test is performed using a sample of the individual's blood or saliva, utilizing advanced genetic sequencing technologies to detect mutations in the TPP1 gene.
The cost of the TPP1 gene test for Spinocerebellar Ataxia Type 7 at DNA Labs UAE is 4400 AED. This price encompasses the comprehensive analysis required to identify any genetic abnormalities within the TPP1 gene. Given the complexity and the specialized nature of this genetic test, the cost reflects the extensive resources, including state-of-the-art technology and expert geneticists, necessary to provide accurate and reliable results.
By opting for this test at DNA Labs UAE, individuals gain crucial insights into their genetic makeup, empowering them with the information needed to make informed health and lifestyle decisions. Additionally, this testing can aid in the genetic counseling process, offering families a clearer understanding of their genetic heritage and the risks of transmitting the condition to future generations.
The ATXN8OS Gene Spinocerebellar Ataxia Type 8 (SCA8) Autosomal Dominant Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE. This test is designed to identify mutations in the ATXN8OS gene, which are associated with the development of Spinocerebellar Ataxia Type 8, a progressive neurodegenerative disorder. SCA8 is characterized by a wide range of symptoms, including coordination and balance difficulties, speech and swallowing problems, and eye movement abnormalities. The condition is inherited in an autosomal dominant manner, meaning that a mutation in just one copy of the gene is sufficient to cause the disorder.
The test is critical for individuals with a family history of SCA8 or those exhibiting symptoms consistent with the condition, as it can provide a definitive diagnosis. Early identification of the disease can help in managing symptoms and planning for future care needs. The testing process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the ATXN8OS gene.
DNA Labs UAE offers this genetic test at a cost of 4400 AED. The facility is equipped with state-of-the-art technology and staffed by experienced professionals to ensure accurate and reliable results. Opting for this test at DNA Labs UAE not only aids in the diagnosis of SCA8 but also contributes to a better understanding of the genetic factors influencing the disorder, potentially guiding treatment options and family planning decisions.
The SYNE1 gene is associated with a condition known as Spinocerebellar Ataxia Type 8 (SCA8), which is a genetic disorder characterized by progressive problems with movement. This condition primarily affects the cerebellum, the part of the brain that controls coordination and balance. Symptoms of SCA8 may include uncoordinated movements, trouble walking, and issues with speech. It is an autosomal recessive disorder, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the condition.
To diagnose this condition, a specific genetic test is available at DNA Labs UAE, which focuses on identifying mutations in the SYNE1 gene that are responsible for SCA8. The test is crucial for confirming the diagnosis, understanding the risk of passing the condition to the next generation, and guiding management and treatment decisions. The cost of the SYNE1 gene Spinocerebellar Ataxia Type 8 Autosomal Recessive Genetic Test at DNA Labs UAE is 4400 AED. This test is a valuable resource for individuals with a family history of SCA8 or those exhibiting symptoms of the disorder, providing them with critical information about their genetic health.
The COQ8A gene spinocerebellar ataxia type 9 (SCAR9) autosomal recessive genetic test is a specialized diagnostic tool used to identify mutations in the COQ8A gene, which are linked to the development of SCAR9. Spinocerebellar ataxia type 9 is a rare genetic disorder characterized by progressive difficulties with coordination and movement, stemming from degeneration in specific areas of the brain, particularly the cerebellum. The autosomal recessive nature of the condition means that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
The test involves analyzing the individual's DNA, extracted from a blood sample, to look for specific genetic alterations in the COQ8A gene that are known to cause SCAR9. This genetic testing is crucial for early diagnosis, which can help in managing symptoms, planning for future healthcare needs, and providing information for family planning decisions.
In the United Arab Emirates, this genetic test is available at DNA Labs UAE, a leading provider of genetic testing services. The cost of the COQ8A gene spinocerebellar ataxia type 9 autosomal recessive genetic test at DNA Labs UAE is 4400 AED. This test is a significant resource for families and individuals at risk of SCAR9, offering them a chance to understand their genetic status and make informed decisions about their health and well-being.
The TDP1 Gene Spinocerebellar Ataxia with Axonal Neuropathy Autosomal Recessive Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the TDP1 gene, which are implicated in the development of spinocerebellar ataxia with axonal neuropathy. This condition is a rare, inherited neurological disorder characterized by a progressive loss of muscle coordination (ataxia) and nerve damage (neuropathy), affecting movement and sensory functions. The test is crucial for individuals with a family history of the disorder or those exhibiting symptoms, providing essential information for accurate diagnosis and management. Priced at 4400 AED, this genetic test involves analyzing the patient's DNA to detect specific mutations in the TDP1 gene, helping in confirming the diagnosis and guiding treatment options, while also offering the possibility for family planning and genetic counseling for affected families.
The ATXN10 gene is associated with Spinocerebellar Ataxia Type 10 (SCA10), a disorder characterized by progressive coordination problems due to the degeneration of the cerebellum in the brain. This condition is inherited in an autosomal dominant pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder. The ATXN10 gene test is a crucial diagnostic tool for identifying mutations within the ATXN10 gene, helping in the diagnosis of SCA10. This genetic test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the ATXN10 gene test at DNA Labs UAE is 4400 AED. This test can provide individuals and families with essential information regarding the genetic basis of Spinocerebellar Ataxia Type 10, facilitating informed decisions about management and care for affected individuals.
The ANO10 gene is associated with a rare form of Spinocerebellar Ataxia, specifically Type 10 (SCA10), which is an autosomal recessive genetic disorder. This condition is characterized by progressive degeneration of the cerebellum, leading to coordination and balance difficulties, among other symptoms. Given the hereditary nature of SCA10, genetic testing is a crucial tool for diagnosis, family planning, and understanding the risk of transmission to offspring.
DNA Labs UAE offers a comprehensive genetic test targeting the ANO10 gene to identify mutations that cause Spinocerebellar Ataxia Type 10. This test is particularly important for individuals with a family history of SCA10 or those exhibiting symptoms suggestive of the condition. The genetic test is priced at 4400 AED and involves analyzing DNA samples to detect the presence of specific mutations in the ANO10 gene that are known to cause the disorder. By confirming a diagnosis through genetic testing, affected individuals can receive appropriate counseling, consider their options for management and treatment, and make informed decisions about family planning.
